Skip to main content
Full access
Letter to the Editor
Published Online: 1 December 2003

Antipsychotic-Induced Paroxysmal Perceptual Alteration

To the Editor: Antipsychotics have sometimes been reported to induce brief and recurrent episodes characterized by hypersensitivity of visual perception (1, 2). However, some researchers still believe that this paroxysmal perceptual alteration is a schizophrenic symptom because the patients with paroxysmal perceptual alteration were diagnosed with schizophrenia. We report on a nonschizophrenic patient who experienced paroxysmal perceptual alteration only during exposure to antipsychotics.
Ms. A, a 49-year-old woman with a 2-year history of generalized anxiety disorder, had suffered from dizziness, anxiety, and syrigmus. Ophthalmologic, otolaryngological, and neurological examinations showed no abnormality, including cataract, and she had good vision and did not wear glasses. Her symptoms did not respond to antidepressants or anxiolytics. Haloperidol, 0.5 mg b.i.d., was added to her regular regimen of alprazolam, 1.2 mg t.i.d., because she became obsessed with her symptoms. Two days after haloperidol treatment was started, the following symptoms occurred: “The fine pattern of the wall and ceiling seems more vivid than usual. I have also noticed that outlines of papers and tiny objects such as dust seem more prominent. These symptoms occur suddenly like an ‘attack’ almost every afternoon and last an hour.”
These symptoms disappeared 2 days after haloperidol treatment was discontinued. Although Ms. A subsequently tried various antidepressants and anxiolytics, none of them ameliorated her original symptoms. Then we prescribed methotrimeprazine (levomepromazine) alone, 10 mg at bedtime, and on the second day she experienced the same symptoms as those induced by haloperidol: “I am having the same ‘attacks.’ Light seems much brighter than usual. Tiny objects like dust and stains seem to be emphasized for a couple of hours every night.”
The bizarre symptoms disappeared soon after we switched the methotrimeprazine to vitamin E, 150 IU/day, as she requested. Her medication regimen has remained the same ever since.
To our knowledge, this is the first report of a nonschizophrenic patient whose exposure to antipsychotics led to paroxysmal perceptual alteration twice. This case shows that this phenomenon can occur in patients treated with antipsychotics regardless of their diagnosis. The evening appearance of this phenomenon might be explained by the circadian pattern of antipsychotic-induced side effects (3). Dopamine receptor antagonists can induce dopamine deficiency in the retina and the visual cortex, which is known to modulate visual processing, including contrast sensitivity (4, 5). The altered visual processing might lead to paroxysmal perceptual alteration. Physicians prescribing antipsychotics should be alert to this potentially important side effect.

References

1.
Yamaguchi N, Nakai H: [Attacks of altered perception in schizophrenics, in Psychopathology of Schizophrenia. Edited by Uchiyama Y.] Tokyo, Tokyo University Press, 1985, pp 295–314 (Japanese)
2.
Higuchi H, Shimizu T, Hishikawa Y: Recurrent paroxysmal episodes characterized by perceptual alteration in three schizophrenic patients on neuroleptic medication. Psychiatry Clin Neurosci 1997; 51:99–101
3.
Mazurek MF, Rosebush PI: Circadian pattern of acute, neuroleptic-induced dystonic reactions. Am J Psychiatry 1996; 153:708–710
4.
Bodis-Wollner I: Visual deficits related to dopamine deficiency in experimental animals and Parkinson’s disease patients. Trends Neurosci 1990; 13:296–307
5.
Masson G, Mestre D, Blin O: Dopaminergic modulation of visual sensitivity in man. Fundam Clin Pharmacol 1993; 7:449–463

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 2243-a - 2244

History

Published online: 1 December 2003
Published in print: December 2003

Authors

Affiliations

KOICHIRO WATANABE, M.D., Ph.D.
GOHEI YAGI, M.D., Ph.D.
HARUO KASHIMA, M.D., Ph.D.
Tokyo, Japan

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share